{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:00:20Z","timestamp":1791810020013,"version":"4.3.4"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bbi.2014.01.018","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:46:51Z","timestamp":1391734011000},"page":"269-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Immune system: A possible nexus between cannabinoids and psychosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Paula","family":"Su\u00e1rez-Pinilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bbi.2014.01.018_b0005","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2012-06-435362","article-title":"Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression","volume":"120","author":"Adhikary","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11481-007-9088-9","article-title":"Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes","volume":"3","author":"Agudelo","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/jop.2011.0049","article-title":"A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits","volume":"27","author":"Altinsoy","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1476-5381.2010.00710.x","article-title":"Regulation of Fas receptor\/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain","volume":"160","author":"Alvaro-Bartolome","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jnr.23114","article-title":"A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury","volume":"90","author":"Amenta","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuropharm.2012.04.012","article-title":"A CB(1)\/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin","volume":"63","author":"Arevalo-Martin","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0035","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1152\/jn.2000.83.6.3287","article-title":"Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons","volume":"83","author":"Auclair","year":"2000","journal-title":"J. Neurophysiol."},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0040","doi-asserted-by":"crossref","first-page":"G1364","DOI":"10.1152\/ajpgi.00191.2011","article-title":"The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor","volume":"302","author":"Avraham","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.bbi.2014.01.018_b0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/mp.2012.37","article-title":"Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction","volume":"17","author":"Ayalew","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0050","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/cr.2011.60","article-title":"GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils","volume":"21","author":"Balenga","year":"2011","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0055","doi-asserted-by":"crossref","first-page":"e67587","DOI":"10.1371\/journal.pone.0067587","article-title":"Cannabinoid receptor 2 (CB2) plays a role in the generation of germinal center and memory B cells, but not in the production of antigen-specific IgG and IgM, in response to T-dependent antigens","volume":"8","author":"Basu","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"Beta-caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARgamma pathway","volume":"178","author":"Bento","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/ern.09.59","article-title":"Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy","volume":"9","author":"Bernstein","year":"2009","journal-title":"Expert Rev. Neurother."},{"issue":"13","key":"10.1016\/j.bbi.2014.01.018_b0070","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"51","key":"10.1016\/j.bbi.2014.01.018_b0075","doi-asserted-by":"crossref","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","article-title":"Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling","volume":"284","author":"Borner","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbi.2014.01.018_b0080","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","article-title":"Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse","volume":"46","author":"Borovcanin","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.imbio.2010.09.004","article-title":"Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1\/CB2 receptors","volume":"216","author":"Braun","year":"2011","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.107.124719","article-title":"Modulation of airway responses to influenza A\/PR\/8\/34 by Delta9-tetrahydrocannabinol in C57BL\/6 mice","volume":"323","author":"Buchweitz","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2014.01.018_b0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2014.01.018_b0100","first-page":"19","article-title":"Experimental methods to study the role of the peripheral cannabinoid receptor in immune function","volume":"123","author":"Buckley","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0105","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbi.2012.08.005","article-title":"Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?","volume":"26","author":"Busse","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187153008785700118","article-title":"Cannabinoids as therapeutic agents for ablating neuroinflammatory disease","volume":"8","author":"Cabral","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.10.027","article-title":"Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae","volume":"147","author":"Cabral","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2014.01.018_b0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/3-540-26573-2_13","article-title":"Effects on the immune system","volume":"168","author":"Cabral","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archpsyc.55.1.67","article-title":"The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study","volume":"55","author":"Cannon","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2007.147652","article-title":"Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia","volume":"58","author":"Caraceni","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2006.03.016","article-title":"Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines","volume":"84","author":"Catts","year":"2006","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0278-5846(98)00059-1","article-title":"Cytokines production in chronic schizophrenia patients with or without paranoid behaviour","volume":"22","author":"Cazzullo","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0145","doi-asserted-by":"crossref","first-page":"e8688","DOI":"10.1371\/journal.pone.0008688","article-title":"Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors","volume":"5","author":"Cencioni","year":"2010","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.bbi.2014.01.018_b0150","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.intimp.2011.11.011","article-title":"Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils","volume":"12","author":"Chen","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2014.01.018_b0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","article-title":"Endocannabinoid-mediated synaptic plasticity in the CNS","volume":"29","author":"Chevaleyre","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2014.01.018_b0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000346157","article-title":"Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia","volume":"35","author":"Chew","year":"2013","journal-title":"Dev. Neurosci."},{"issue":"7\u20138","key":"10.1016\/j.bbi.2014.01.018_b0170","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.intimp.2009.03.006","article-title":"Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts","volume":"9","author":"Chicca","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2014.01.018_b0175","first-page":"27","article-title":"Cannabinoid receptors: G-protein-mediated signal transduction mechanisms","volume":"59","author":"Childers","year":"1993","journal-title":"Biochem. Soc. Symp."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.intimp.2006.11.008","article-title":"Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis","volume":"7","author":"Coopman","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2008.09.014","article-title":"A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells","volume":"77","author":"Correa","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/glia.20907","article-title":"Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1\/2, JNK, and NF-kappaB","volume":"58","author":"Correa","year":"2010","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2006.08.005","article-title":"Interleukin-12 plasma levels in drug-naive patients with a first episode of psychosis: effects of antipsychotic drugs","volume":"158","author":"Crespo-Facorro","year":"2008","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.bbi.2014.01.018_b0200","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1462-5822.2005.00577.x","article-title":"Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression","volume":"7","author":"Croxford","year":"2005","journal-title":"Cell. Microbiol."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0205","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1172\/JCI67569","article-title":"Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure","volume":"123","author":"Cutando","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2014.01.018_b0210","doi-asserted-by":"crossref","first-page":"451865","DOI":"10.5402\/2012\/451865","article-title":"Synergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the \u201cTwo Hit\u201d hypothesis for the development of schizophrenia","volume":"2012","author":"Dalton","year":"2012","journal-title":"ISRN Psychiatr."},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0215","doi-asserted-by":"crossref","first-page":"e28159","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","volume":"6","author":"De Filippis","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0220","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/schbul\/18.2.209","article-title":"The significance of age of onset for schizophrenia","volume":"18","author":"DeLisi","year":"1992","journal-title":"Schizophr. Bull."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-5728(03)00259-5","article-title":"No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes","volume":"141","author":"Deusch","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"5090","key":"10.1016\/j.bbi.2014.01.018_b0230","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0235","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.173.4.2373","article-title":"Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation","volume":"173","author":"Do","year":"2004","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0240","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1074\/jbc.M110.188599","article-title":"Identification of the synthetic cannabinoid R(+)WIN55,212\u20132 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis","volume":"286","author":"Downer","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neuropharm.2012.05.008","article-title":"Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system","volume":"63","author":"Dutra","year":"2012","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0250","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","article-title":"Autoimmune diseases, bipolar disorder, and non-affective psychosis","volume":"12","author":"Eaton","year":"2010","journal-title":"Bipolar Disord."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0255","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2014.01.018_b0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflamm."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2007.06.001","article-title":"Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors","volume":"189","author":"Eisenstein","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/0960327104ht426oa","article-title":"Effect of cannabinoid ingestion (in the form of bhang) on the immune system of high school and university students","volume":"23","author":"El-Gohary","year":"2004","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0280","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","article-title":"Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury","volume":"25","author":"Esposito","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"10\u201311","key":"10.1016\/j.bbi.2014.01.018_b0285","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1567-5769(03)00163-2","article-title":"Cannabinoids inhibit the activation of ERK MAPK in PMA\/Io-stimulated mouse splenocytes","volume":"3","author":"Faubert Kaplan BL","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1612-6","article-title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia","volume":"206","author":"Fernandez-Espejo","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"5217","key":"10.1016\/j.bbi.2014.01.018_b0295","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.7777856","article-title":"Linked regularities in the development and evolution of mammalian brains","volume":"268","author":"Finlay","year":"1995","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.bbi.2014.01.018_b0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(03)02074-0","article-title":"Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors","volume":"474","author":"Franklin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bbi.2014.01.018_b0305","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"Franklin","year":"2003","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0310","first-page":"24","article-title":"The endocannabinoid-CB receptor system: importance for development and in pediatric disease","volume":"25","author":"Fride","year":"2004","journal-title":"Neuro. Endocrinol. Lett."},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0315","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/all.12183","article-title":"Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors","volume":"68","author":"Gaffal","year":"2013","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0320","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archpsyc.1995.03950200058014","article-title":"Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms","volume":"52","author":"Ganguli","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2014.01.018_b0325","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","author":"Garcia-Bueno","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0330","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ymeth.2012.04.002","article-title":"Dysequilibrium of neuronal proliferation and apoptosis in a pharmacological animal model of psychosis","volume":"56","author":"Genius","year":"2012","journal-title":"Methods"},{"issue":"14","key":"10.1016\/j.bbi.2014.01.018_b0335","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.molimm.2006.01.005","article-title":"Cannabinoid receptor CB2 modulates the CXCL12\/CXCR4-mediated chemotaxis of T lymphocytes","volume":"43","author":"Ghosh","year":"2006","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0340","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1248\/bpb.30.1199","article-title":"2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells","volume":"30","author":"Gokoh","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2003.09.006","article-title":"Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940","volume":"91","author":"Gongora","year":"2004","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11481-010-9225-8","article-title":"Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS","volume":"5","author":"Gorantla","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2014.01.018_b0355","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2741\/3288","article-title":"Cannabinoid receptors: a brief history and \u201cwhat\u2019s hot\u201d","volume":"14","author":"Graham","year":"2009","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2013.04.032","article-title":"Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability","volume":"63","author":"Harvey","year":"2013","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0370","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/eji.201040667","article-title":"Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties","volume":"40","author":"Hegde","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0375","doi-asserted-by":"crossref","first-page":"e18281","DOI":"10.1371\/journal.pone.0018281","article-title":"Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol","volume":"6","author":"Hegde","year":"2011","journal-title":"PLoS ONE"},{"issue":"4 Suppl","key":"10.1016\/j.bbi.2014.01.018_b0380","first-page":"S17","article-title":"Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?","volume":"190","author":"Hickie","year":"2009","journal-title":"Med. J. Aust."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0385","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1389557054368844","article-title":"CB2 receptor ligands","volume":"5","author":"Huffman","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0390","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0395","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.intimp.2007.01.015","article-title":"Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB\/c mice","volume":"7","author":"Jan","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0400","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00262-004-0509-9","article-title":"Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes","volume":"53","author":"Joseph","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0405","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0410","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1189\/jlb.0511219","article-title":"Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection","volume":"90","author":"Karmaus","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0415","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/toxsci\/kfs315","article-title":"Delta9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2","volume":"131","author":"Karmaus","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0420","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.psyneuen.2008.02.009","article-title":"Anandamide and neutrophil function in patients with fibromyalgia","volume":"33","author":"Kaufmann","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0425","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pnpbp.2004.05.047","article-title":"Th1, Th2 and Th3 cytokine alteration in schizophrenia","volume":"28","author":"Kim","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0430","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2009.09.040","article-title":"A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction","volume":"74","author":"Kinney","year":"2010","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0435","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0440","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvh063","article-title":"2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells","volume":"135","author":"Kishimoto","year":"2004","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbi.2014.01.018_b0445","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.160.4.533","article-title":"Can autoimmune mechanisms account for the genetic predisposition to schizophrenia?","volume":"160","author":"Knight","year":"1992","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0450","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.lfs.2004.02.007","article-title":"Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide","volume":"75","author":"Kraft","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2014.01.018_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06524.x","article-title":"Expression and functions of mu-opioid receptors and cannabinoid receptors type 1 in T lymphocytes","volume":"1261","author":"Kraus","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0460","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<4::AID-AJMG2>3.0.CO;2-J","article-title":"Twin studies in schizophrenia with special emphasis on concordance figures","volume":"97","author":"Kringlen","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"11","key":"10.1016\/j.bbi.2014.01.018_b0465","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/glia.22380","article-title":"Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation","volume":"60","author":"Krishnan","year":"2012","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0470","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0475","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","article-title":"Cannabis and psychiatric disorders: it is not only addiction","volume":"13","author":"Leweke","year":"2008","journal-title":"Addict. Biol."},{"issue":"1\u20133","key":"10.1016\/j.bbi.2014.01.018_b0480","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","article-title":"Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use","volume":"94","author":"Leweke","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2014.01.018_b0485","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0490","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.leukres.2005.01.014","article-title":"Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells","volume":"29","author":"Lombard","year":"2005","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0495","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1124\/jpet.111.181206","article-title":"Perinatal exposure to Delta9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens","volume":"339","author":"Lombard","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0500","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.molimm.2011.09.016","article-title":"Targeting CB(2) receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis","volume":"49","author":"Lou","year":"2011","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0505","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jnr.22721","article-title":"Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist","volume":"90","author":"Lou","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"1390","key":"10.1016\/j.bbi.2014.01.018_b0510","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2011.03.020","article-title":"Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis","volume":"16","author":"Lourbopoulos","year":"2011","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.bbi.2014.01.018_b0515","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.181.9.6406","article-title":"Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells","volume":"181","author":"Lu","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0520","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1189\/jlb.0608390","article-title":"Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol","volume":"85","author":"Lu","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0525","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.105.093500","article-title":"A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo","volume":"316","author":"Lunn","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"15","key":"10.1016\/j.bbi.2014.01.018_b0530","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1096\/fj.04-2190fje","article-title":"The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein","volume":"18","author":"Maestroni","year":"2004","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0535","doi-asserted-by":"crossref","first-page":"e62511","DOI":"10.1371\/journal.pone.0062511","article-title":"Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis","volume":"8","author":"Malfitano","year":"2013","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0540","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jim.2011.08.021","article-title":"Endocannabinoid content in fetal bovine sera \u2013 unexpected effects on mononuclear cells and osteoclastogenesis","volume":"373","author":"Marazzi","year":"2011","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.bbi.2014.01.018_b0545","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/art.27642","article-title":"Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis","volume":"62","author":"Marquart","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1\u20133","key":"10.1016\/j.bbi.2014.01.018_b0550","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.09.020","article-title":"A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia","volume":"133","author":"Matheson","year":"2011","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0555","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1358\/dnp.2008.21.4.1213349","article-title":"The complement system in schizophrenia","volume":"21","author":"Mayilyan","year":"2008","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.bbi.2014.01.018_b0560","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0565","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.01.018_b0570","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/tp.2011.37","article-title":"Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype","volume":"1","author":"McKernan","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2014.01.018_b0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0580","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2011.01673.x","article-title":"Cannabinoid CB(2) receptors modulate ERK-1\/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide","volume":"165","author":"Merighi","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0585","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.2004.02979.x","article-title":"Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis","volume":"92","author":"Mestre","year":"2005","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0590","doi-asserted-by":"crossref","first-page":"G181","DOI":"10.1152\/ajpgi.00133.2012","article-title":"Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms","volume":"304","author":"Michler","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0595","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0600","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.159.6.2994","article-title":"Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease","volume":"159","author":"Mittleman","year":"1997","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0605","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/jpet.109.163998","article-title":"Anti-inflammatory properties of CB1-receptor antagonist involves beta2 adrenoceptors","volume":"333","author":"Mnich","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(97)00179-6","article-title":"Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders","volume":"22","author":"Muller","year":"1998","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0615","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/15622970009150588","article-title":"Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation","volume":"1","author":"Muller","year":"2000","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2014.01.018_b0620","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","article-title":"The immune system and schizophrenia. An integrative view","volume":"917","author":"Muller","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0625","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/14737175.8.7.1037","article-title":"Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia","volume":"8","author":"Muller-Vahl","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0630","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1084\/jem.20111083","article-title":"Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone","volume":"208","author":"Muppidi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0635","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1189\/jlb.0304184","article-title":"The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2","volume":"76","author":"Newton","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0640","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11481-008-9126-2","article-title":"CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection","volume":"4","author":"Newton","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0645","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","article-title":"Win 55212\u20132, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model","volume":"10","author":"Ni","year":"2004","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0650","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","article-title":"Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials","volume":"39","author":"Nitta","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0655","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.bjc.6605248","article-title":"Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2","volume":"101","author":"Olea-Herrero","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbi.2014.01.018_b0660","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0074-7742(09)88012-4","article-title":"Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications","volume":"88","author":"Onaivi","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0665","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"13","key":"10.1016\/j.bbi.2014.01.018_b0670","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1096\/fj.06-6164fje","article-title":"Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation","volume":"20","author":"Palazuelos","year":"2006","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.bbi.2014.01.018_b0675","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2174\/1381612003399419","article-title":"Natural and synthetic endocannabinoids and their structure-activity relationships","volume":"6","author":"Palmer","year":"2000","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0680","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jep.2007.10.023","article-title":"The effects of Morinda citrifolia L. (noni) on the immune system: its molecular mechanisms of action","volume":"115","author":"Palu","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0685","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/jpet.111.182717","article-title":"Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model","volume":"338","author":"Pandey","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2014.01.018_b0690","doi-asserted-by":"crossref","first-page":"257184","DOI":"10.1155\/2013\/257184","article-title":"Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives","volume":"2013","author":"Pathmanandavel","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbi.2014.01.018_b0695","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1478-811X-9-33","article-title":"The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins","volume":"9","author":"Paulsen","year":"2011","journal-title":"Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0700","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/mol.109.062257","volume":"77","author":"Pellerito","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"6\u20137","key":"10.1016\/j.bbi.2014.01.018_b0705","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0024-3205(99)00282-9","article-title":"Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors","volume":"65","author":"Pertwee","year":"1999","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.bbi.2014.01.018_b0710","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt. 10","key":"10.1016\/j.bbi.2014.01.018_b0715","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awg224","article-title":"Cannabinoids inhibit neurodegeneration in models of multiple sclerosis","volume":"126","author":"Pryce","year":"2003","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.bbi.2014.01.018_b0720","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4628-11.2012","article-title":"Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions","volume":"32","author":"Ramirez","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0725","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0730","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phrs.2009.03.006","article-title":"Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids","volume":"60","author":"Realini","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0735","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000339113","article-title":"Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat","volume":"19","author":"Rettori","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2014.01.018_b0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2012.11.003","article-title":"Involvement of ERK1\/2, cPLA2 and NF-kappaB in microglia suppression by cannabinoid receptor agonists and antagonists","volume":"100\u2013101","author":"Ribeiro","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0745","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11481-013-9485-1","article-title":"Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction","volume":"8","author":"Robinson","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0750","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11481-006-9040-4","article-title":"WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors","volume":"2","author":"Rock","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0755","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.104.065524","article-title":"A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes","volume":"311","author":"Rockwell","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0760","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.ajpath.2013.07.033","article-title":"Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier","volume":"183","author":"Rom","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0765","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2010.12.005","article-title":"Inverse agonism of cannabinoid CB1 receptor blocks the adhesion of encephalitogenic T cells in inflamed brain venules by a protein kinase A-dependent mechanism","volume":"233","author":"Rossi","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.bbi.2014.01.018_b0770","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.lfs.2005.05.014","article-title":"Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse","volume":"77","author":"Roth","year":"2005","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0775","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2004.10.003","article-title":"The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro","volume":"159","author":"Sacerdote","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0780","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mp.2012.165","article-title":"Inflammatory and immune response genes have significantly altered expression in schizophrenia","volume":"18","author":"Sainz","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0785","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbadis.2009.07.008","article-title":"Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death","volume":"1792","author":"Saunders","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0790","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/mehy.2000.1203","article-title":"The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms","volume":"56","author":"Schwarz","year":"2001","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0795","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","article-title":"Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis","volume":"177","author":"Servettaz","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0800","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.icb.7100121","article-title":"Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis","volume":"86","author":"Shiratsuchi","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0805","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2011.11.005","article-title":"Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(\u2212\/\u2212) mice by attenuating the activation of T cells and promoting their apoptosis","volume":"258","author":"Singh","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0810","doi-asserted-by":"crossref","first-page":"e76907","DOI":"10.1371\/journal.pone.0076907","article-title":"Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 Receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis","volume":"8","author":"Sisay","year":"2013","journal-title":"PLoS ONE"},{"issue":"1607","key":"10.1016\/j.bbi.2014.01.018_b0815","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1098\/rstb.2012.0313","article-title":"Endocannabinoids in nervous system health and disease: the big picture in a nutshell","volume":"367","author":"Skaper","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0820","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator","volume":"48","author":"Skaper","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0825","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1189\/jlb.0508282","article-title":"Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune compete nce and sensitivity to immune modulation by Delta9-tetrahydrocannabinol","volume":"84","author":"Springs","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"7256","key":"10.1016\/j.bbi.2014.01.018_b0830","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0835","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization","volume":"112","author":"Steiner","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbi.2014.01.018_b0840","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bbi.2014.01.018_b0845","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: an overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.bbi.2014.01.018_b0850","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1348-0421.2007.tb03985.x","article-title":"Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice","volume":"51","author":"Tanikawa","year":"2007","journal-title":"Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2014.01.018_b0855","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1248\/bpb.34.1090","article-title":"Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis","volume":"34","author":"Tanikawa","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"1283","key":"10.1016\/j.bbi.2014.01.018_b0860","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"4","author":"Tolon","year":"2009","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0865","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.06578.x","article-title":"Evidence that MDMA (\u2018ecstasy\u2019) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain","volume":"113","author":"Torres","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0870","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","article-title":"A combined preclinical therapy of cannabinoids and temozolomide against glioma","volume":"10","author":"Torres","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0875","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0880","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","article-title":"The cannabinoid receptor 2 is critical for the host response to sepsis","volume":"183","author":"Tschop","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2014.01.018_b0885","first-page":"A1874","article-title":"Psychosis: from diagnosis to syndrome","volume":"154","author":"van Os","year":"2010","journal-title":"Ned. Tijdschr. Geneeskd."},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0890","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00001504-200503000-00006","article-title":"The schizophrenia envirome","volume":"18","author":"van Os","year":"2005","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0895","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/jpet.104.068635","article-title":"The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids","volume":"311","author":"Vannacci","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0900","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","article-title":"Cannabis use and age at onset of schizophrenia","volume":"161","author":"Veen","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2014.01.018_b0905","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-6606-6-42","article-title":"HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity","volume":"6","author":"Vicente-Sanchez","year":"2013","journal-title":"Mol. Brain"},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0910","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0915","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.181.5.3057","article-title":"Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity","volume":"181","author":"Wacnik","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0920","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbi.2014.01.018_b0925","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jnr.20570","article-title":"Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25\u201335)-induced oxidative stress and the ensuing apoptosis","volume":"81","author":"Wang","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"14","key":"10.1016\/j.bbi.2014.01.018_b0930","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1002\/jnr.21757","article-title":"High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells","volume":"86","author":"Widmer","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.bbi.2014.01.018_b0935","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02190280","article-title":"Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients","volume":"246","author":"Wilke","year":"1996","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2014.01.018_b0940","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1189\/jlb.0307159","article-title":"Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis","volume":"82","author":"Xu","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2014.01.018_b0945","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.tox.2013.10.007","article-title":"Delta(8)-tetrahydrocannabinol induces cytotoxicity in macrophage J774-1 cells: Involvement of cannabinoid receptor 2 and p38 MAPK","volume":"314","author":"Yamaori","year":"2013","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.bbi.2014.01.018_b0950","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cellsig.2012.10.015","article-title":"Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury","volume":"25","author":"Yang","year":"2013","journal-title":"Cell. Signal."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2014.01.018_b0955","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","article-title":"Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6","volume":"643","author":"Zalcman","year":"1994","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbi.2014.01.018_b0960","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/syn.21640","article-title":"Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat","volume":"67","author":"Zavitsanou","year":"2013","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.bbi.2014.01.018_b0965","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00251-006-0138-x","article-title":"Formation of B and T cell subsets require the cannabinoid receptor CB2","volume":"58","author":"Ziring","year":"2006","journal-title":"Immunogenetics"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:38:01Z","timestamp":1760168281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":193,"alternative-id":["S0889159114000439"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.01.018","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune system: A possible nexus between cannabinoids and psychosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}